Maria R. Costanzo
Distinguished in Pulmonary Veno-Occlusive Disease

Dr. Maria R. Costanzo

Advanced Heart Failure and Transplant Cardiology | Cardiology
801 S Washington St Fl 4, 
Naperville, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Distinguished in Pulmonary Veno-Occlusive Disease
801 S Washington St Fl 4, 
Naperville, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Maria Costanzo is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Naperville, Illinois. Dr. Costanzo is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, and Heart Transplant. Dr. Costanzo is currently accepting new patients.

Her clinical research consists of co-authoring 101 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Cardiology
Licenses
Internal Medicine in IL
Languages Spoken
English
French
Italian
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

801 S Washington St Fl 4, Naperville, IL 60540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Hemodynamic-GUIDEd Management of Heart Failure
Hemodynamic-GUIDEd Management of Heart Failure
Enrollment Status: Completed
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Feasibility Study on Ultrafiltration and Blood Volume Measurements
A Feasibility Study on Ultrafiltration and Blood Volume Measurements
Enrollment Status: Terminated
Publish Date: November 14, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Enrollment Status: Unknown
Publish Date: January 23, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Enrollment Status: Terminated
Publish Date: December 29, 2017
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 7 Less Clinical Trials

101 Total Publications

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.
Journal: Heart, lung & circulation
Published: May 22, 2025
Similar Doctors
Muhyaldeen Dia
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. Muhyaldeen Dia
Advanced Heart Failure and Transplant Cardiology
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. Muhyaldeen Dia
Advanced Heart Failure and Transplant Cardiology

Advocate Heart Institute

10837 S Cicero Ave, Ste 200, 
Oak Lawn, IL 
 (21.5 miles away)
708-636-7575
Languages Spoken:
English
See accepted insurances

Muhyaldeen Dia is an Advanced Heart Failure and Transplant Cardiologist in Oak Lawn, Illinois. Dr. Dia is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, Pulmonary Edema, and Heart Transplant.

Sunil Pauwaa
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. Sunil Pauwaa
Advanced Heart Failure and Transplant Cardiology
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. Sunil Pauwaa
Advanced Heart Failure and Transplant Cardiology

Advocate Heart Institute

10837 S Cicero Ave, Ste 200, 
Oak Lawn, IL 
 (21.5 miles away)
708-636-7575
Languages Spoken:
English
See accepted insurances

Sunil Pauwaa is an Advanced Heart Failure and Transplant Cardiologist in Oak Lawn, Illinois. Dr. Pauwaa is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Heart Failure, Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Hypertensive Heart Disease, and Heart Transplant.

James P. Sur
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. James P. Sur
Cardiology
Distinguished in Pulmonary Veno-Occlusive Disease
Dr. James P. Sur
Cardiology

Heart Care Centers Of Illinois, SC

13011 S 104th Ave, 
Palos Park, IL 
 (16.1 miles away)
708-274-3278
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Sur is a Cardiologist in Palos Park, Illinois. Dr. Sur is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Coronary Heart Disease, Pulmonary Veno-Occlusive Disease, Atherosclerosis, Pulmonary Hypertension, and Heart Bypass Surgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Costanzo's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile